chemotherapy

Mycobacterioses are caused by multiple opportunistic bacteria that are ubiquitous. The incidence rate of nontuberculosis mycobacterial infections (NTM) is rising due to an increased number of immunocompromised patients and advances in diagnosis. …

This article describes clinical development stages for the novel anti-TB drug «Perchlozone®», which has been approved in Russian Federation in 2012. Based on the phase I–III clinical studies results, efficacy and safety of the drug were assessed, and …

In spite of the fact that legionellosis is known as a human infectious disease for more than 25 years there is still quite a few difficulties and open problems. At the present article the following topics are described in detail: taxonomy, general …

Translated and reprinted with permission from «Emerging Infectious Diseases» 2000; 6:552-6.

Resistance of Streptococcus pneumoniae to antimicrobial drug is increasing. To investigate the relationship between antimicrobial use and …

Candiduria is relatively infrequent condition that occurs in less than 5% hospitalised patients and accounts for difficulties in diagnosis and patient’s investigation. The main problem is a difficulty in a differentiation of the true fungal …

In spite of the fact that legionellosis is known as a human infectious disease for more than 25 years there is still quite a few difficulties and open problems. At the present article the following topics are described in detail: taxonomy, general …